Shelby Sullivan, MD
Professor, Medicine-Gastroenterology

Photo
Medical School:
  • MD, Washington University in St. Louis School of Medicine (2001)
Undergraduate School:
  • BA, University of Wisconsin–Madison (WI) (1997)
Internship:
  • Washington University in St. Louis (2002)
Residency:
  • Washington University in St. Louis, Internal Medicine (2004)
Fellowships:
  • Washington University in St. Louis, Gastroenterology (2007)
Department: Medicine-Gastroenterology

Professional Titles

  • Director of the Gastroenterology Metabolic and Bariatric Program
  • PLEASE NOTE: I see patients for weight loss related clinic visits at the Anschutz Health and Wellness Center.

Research Interests

My research interest focus on treating obesity and obesity related diseases. I have been an investigator on seven FDA trials for endoscopic weight loss devices and procedures. I also study the metabolic effects of diet and exercise on nonalcoholic fatty liver disease.

Publications

  • Swei E, Almuhaidb A, Sullivan S, Al-Shahrani A, D'Souza FR, Altayar O, Bell S, Maday R, Wagh MS, Mullady D, Bennett M, Early D, Kushnir V. Comparison of the Efficacy and Safety of the FDA-approved Intragastric Balloon Systems in a Clinical Setting. J Clin Gastroenterol. 2022 May 24. [Epub ahead of print] PubMed PMID: 35604348
  • Jirapinyo P, Kumar N, Saumoy M, Copland A, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for aspiration therapy. Gastrointest Endosc. 2021 Feb;93(2):334-342.e1. PubMed PMID: 33218669
  • Jirapinyo P, Kumar N, Saumoy M, Copland A, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for aspiration therapy. Gastrointest Endosc. 2021 Feb;93(2):334-342.e1. PubMed PMID: 33218669
  • Jirapinyo P, Kumar N, Saumoy M, Copland A, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for aspiration therapy. Gastrointest Endosc. 2021 Feb;93(2):334-342.e1. PubMed PMID: 33218669
  • Kumar N, Dayyeh BA, Dunkin BJ, Neto MG, Gomez V, Jonnalagadda S, Kumbhari V, Larsen MC, Pannala R, Ryou MK, Sullivan SA, Wilson EB, Thompson CC. ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies. Gastrointest Endosc. 2020 Jun;91(6):1230-1233. PubMed PMID: 31558279
  • Swei EC, Sullivan SA. Aspiration Therapy. Tech Vasc Interv Radiol. 2020 Mar;23(1):100659. PubMed PMID: 32192639
  • Pannala R, Sharaiha RZ, Sullivan SA, Wagh MS, Cohen J, Thompson CC. Obesity core curriculum. Gastrointest Endosc. 2020 Jun;91(6):1221-1229. PubMed PMID: 31302093
  • Jensen T, Wieland A, Cree-Green M, Nadeau K, Sullivan S. Clinical workup of fatty liver for the primary care provider. Postgrad Med. 2019 Jan;131(1):19-30. PubMed PMID: 30496690
  • Kumar N, Dayyeh BA, Dunkin BJ, Neto MG, Gomez V, Jonnalagadda S, Kumbhari V, Larsen MC, Pannala R, Ryou MK, Sullivan SA, Wilson EB, Thompson CC. TEMPORARY REMOVAL: ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies. Gastrointest Endosc. 2019 Sep 23. [Epub ahead of print] PubMed PMID: 31558279
  • Thompson CC, Abu Dayyeh BK, Kushnir V, Kushner RF, Jirapinyo P, Schorr AB, Aronne LJ, Amaro A, Jaffe DL, Schulman AR, Early D, Stein AC, Sharaiha R, Edmundowicz SA, Bohning JM, Jensen MD, Shukla AP, Apovian C, Kim DW, Tran D, Zarrinpar A, Ryan MB, Young M, Lowe A, Haas M, Goldsmith H, McCrea J, Sullivan S. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surg Obes Relat Dis. 2019 Aug;15(8):1348-1354. PubMed PMID: 31302000
  • Moore RL, Seger MV, Garber SM, Smith AB, Nguyen RT, Shieh MK, Snow RG, Sullivan S. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization. Surg Obes Relat Dis. 2019 Mar;15(3):417-423. PubMed PMID: 30797717
  • Thompson CC, Abu Dayyeh BK, Kushnir V, Kushner RF, Jirapinyo P, Schorr AB, Aronne LJ, Amaro A, Jaffe DL, Schulman AR, Early D, Stein AC, Sharaiha R, Edmundowicz SA, Bohning JM, Jensen MD, Shukla AP, Apovian C, Kim DW, Tran D, Zarrinpar A, Ryan MB, Young M, Lowe A, Haas M, Goldsmith H, McCrea J, Sullivan S. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surg Obes Relat Dis. 2019 Aug;15(8):1348-1354. PubMed PMID: 31302000
  • Bhandari M, Fobi MAL, Buchwald JN. Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg. 2019 Jul;29(Suppl 4):309-345. PubMed PMID: 31297742
  • Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease. J Hepatol. 2018 Jan 31. [Epub ahead of print] PubMed PMID: 29408694
  • Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, Barish CF, Pruitt R, Cash BD, Quirk D, Tiongco F, Sullivan S, Bernstein D. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018 Sep;88(3):427-437.e6. PubMed PMID: 29723512
  • Agnihotri A, Xie A, Bartalos C, Kushnir V, Islam S, Islam E, Lamet M, Lamet A, Farboudmanesch R, Overholt BF, Altawil J, Early DS, Bennett M, Lowe A, Mullady DK, Adeyeri CS, El Zein M, Mishra P, Fayad L, Dunlap M, Oberbach A, Cheskin LJ, Kalloo AN, Khashab MA, Kumbhari V. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss. Clin Gastroenterol Hepatol. 2018 Jul;16(7):1081-1088.e1. PubMed PMID: 29481969
  • Sullivan S, Swain J, Woodman G, Edmundowicz S, Hassanein T, Shayani V, Fang JC, Noar M, Eid G, English WJ, Tariq N, Larsen M, Jonnalagadda SS, Riff DS, Ponce J, Early D, Volckmann E, Ibele AR, Spann MD, Krishnan K, Bucobo JC, Pryor A. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018 Dec;14(12):1876-1889. PubMed PMID: 30545596
  • Trindade AJ, Lichtenstein DR, Aslanian HR, Bhutani MS, Goodman A, Melson J, Navaneethan U, Pannala R, Parsi MA, Sethi A, Sullivan S, Thosani N, Trikudanathan G, Watson RR, Maple JT. Devices and methods to improve colonoscopy completion (with videos). Gastrointest Endosc. 2018 Mar;87(3):625-634. PubMed PMID: 29454445
  • Watson RR, Parsi MA, Aslanian HR, Goodman AJ, Lichtenstein DR, Melson J, Navaneethan U, Pannala R, Sethi A, Sullivan SA, Thosani NC, Trikudanathan G, Trindade AJ, Maple JT. Biliary and pancreatic lithotripsy devices. VideoGIE. 2018 Nov;3(11):329-338. PubMed PMID: 30402576
  • Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018 May;68(5):1063-1075. PubMed PMID: 29408694
  • Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, Barish CF, Pruitt R, Cash BD, Quirk D, Tiongco F, Sullivan S, Bernstein D. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018 Sep;88(3):427-437.e6. PubMed PMID: 29723512
  • Agnihotri A, Xie A, Bartalos C, Kushnir V, Sullivan S, Islam S, Islam E, Lamet M, Lamet A, Farboudmanesch R, Overholt BF, Altawil J, Early DS, Bennett M, Lowe A, Mullady DK, Adeyeri CS, El Zein M, Mishra P, Fayad L, Dunlap M, Oberbach A, Cheskin LJ, Kalloo AN, Khashab MA, Kumbhari V. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss. Clin Gastroenterol Hepatol. 2018 Jul;16(7):1081-1088.e1. PubMed PMID: 29481969
  • Sullivan S, Swain J, Woodman G, Edmundowicz S, Hassanein T, Shayani V, Fang JC, Noar M, Eid G, English WJ, Tariq N, Larsen M, Jonnalagadda SS, Riff DS, Ponce J, Early D, Volckmann E, Ibele AR, Spann MD, Krishnan K, Bucobo JC, Pryor A. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018 Dec;14(12):1876-1889. PubMed PMID: 30545596
  • Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology. 2017 Feb 9. [Epub ahead of print] PubMed PMID: 28192103
  • Sullivan S, Swain JM, Woodman G, Antonetti M, De La Cruz-Muñoz N, Jonnalagadda SS, Ujiki M, Ikramuddin S, Ponce J, Ryou M, Reynoso J, Chhabra R, Sorenson GB, Clarkston WK, Edmundowicz SA, Eagon JC, Mullady DK, Leslie D, Lavin TE, Thompson CC. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring). 2017 Feb;25(2):294-301. PubMed PMID: 28000425
  • Sullivan S, Edmundowicz S. Early Experience With Endoscopic Sleeve Gastroplasty and Hints at Mechanisms of Action. Clin Gastroenterol Hepatol. 2017 Jan;15(1):44-45. PubMed PMID: 27693522
  • Sullivan S. Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes. Diabetes Spectr. 2017 Nov;30(4):258-264. PubMed PMID: 29151716
  • Magkos F, Sullivan S, Fitch M, Smith G, Fabbrini E, Mittendorfer B, Hellerstein M, Klein S. Effect of Weight Gain and Weight Loss on In Vivo Colonocyte Proliferation Rate in People with Obesity. Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S81-S86. PubMed PMID: 29086514
  • Thosani N, Goodman A, Manfredi M, Navaneethan U, Parsi MA, Smith ZL, Sullivan SA, Banerjee S, Maple JT. Endoscopic anti-reflux devices (with videos). Gastrointest Endosc. 2017 Dec;86(6):931-948. PubMed PMID: 29054276
  • Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Gastrointest Endosc. 2017 Nov;86(5):757-767. PubMed PMID: 29031371
  • Kumar N, Sullivan S, Thompson CC. The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy. Diabetes Metab Syndr Obes. 2017;10:311-316. PubMed PMID: 28740414
  • Sullivan S, Swain JM, Woodman G, Antonetti M, De La Cruz-Muñoz N, Jonnalagadda SS, Ujiki M, Ikramuddin S, Ponce J, Ryou M, Reynoso J, Chhabra R, Sorenson GB, Clarkston WK, Edmundowicz SA, Eagon JC, Mullady DK, Leslie D, Lavin TE, Thompson CC. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring). 2017 Feb;25(2):294-301. PubMed PMID: 28000425
  • Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017 Mar;112(3):447-457. PubMed PMID: 27922026
  • Magkos F, Sullivan S, Fitch M, Smith G, Fabbrini E, Mittendorfer B, Hellerstein M, Klein S. Effect of Weight Gain and Weight Loss on In Vivo Colonocyte Proliferation Rate in People with Obesity. Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S81-S86. PubMed PMID: 29086514
  • Sullivan S. Aspiration Therapy for Obesity. Gastrointest Endosc Clin N Am. 2017 Apr;27(2):277-288. PubMed PMID: 28292406
  • Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology. 2017 May;152(7):1791-1801. PubMed PMID: 28192103
  • Kumbhari V, Hill C, Sullivan S. Bariatric endoscopy: state-of-the-art. Curr Opin Gastroenterol. 2017 Sep;33(5):358-365. PubMed PMID: 28682794
  • Thosani N, Goodman A, Manfredi M, Navaneethan U, Parsi MA, Smith ZL, Sullivan SA, Banerjee S, Maple JT. Endoscopic anti-reflux devices (with videos). Gastrointest Endosc. 2017 Dec;86(6):931-948. PubMed PMID: 29054276
  • Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Gastrointest Endosc. 2017 Nov;86(5):757-767. PubMed PMID: 29031371
  • Sullivan S. Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes. Diabetes Spectr. 2017 Nov;30(4):258-264. PubMed PMID: 29151716
  • Hwang JH, Aslanian HR, Thosani N, Goodman A, Manfredi M, Navaneethan U, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S, Maple JT. Devices for use with EUS. VideoGIE. 2017 Mar;2(3):35-45. PubMed PMID: 29905238
  • Navaneethan U, Thosani N, Goodman A, Manfredi M, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S, Maple JT. Radiofrequency ablation devices. VideoGIE. 2017 Oct;2(10):252-259. PubMed PMID: 29905337
  • Sullivan S, Swain JM, Woodman G, Antonetti M, De La Cruz-Muñoz N, Jonnalagadda SS, Ujiki M, Ikramuddin S, Ponce J, Ryou M, Reynoso J, Chhabra R, Sorenson GB, Clarkston WK, Edmundowicz SA, Eagon JC, Mullady DK, Leslie D, Lavin TE, Thompson CC. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring). 2017 Feb;25(2):294-301. PubMed PMID: 28000425
  • Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017 Mar;112(3):447-457. PubMed PMID: 27922026
  • Magkos F, Sullivan S, Fitch M, Smith G, Fabbrini E, Mittendorfer B, Hellerstein M, Klein S. Effect of Weight Gain and Weight Loss on In Vivo Colonocyte Proliferation Rate in People with Obesity. Obesity (Silver Spring). 2017 Nov;25 Suppl 2(Suppl 2):S81-S86. PubMed PMID: 29086514
  • Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2016 Dec 6. [Epub ahead of print] PubMed PMID: 27922026
  • Parsi MA, Sullivan SA, Goodman A, Manfredi M, Navaneethan U, Pannala R, Smith ZL, Thosani N, Banerjee S, Maple JT. Automated endoscope reprocessors. Gastrointest Endosc. 2016 Dec;84(6):885-892. PubMed PMID: 27765382
  • Sullivan S, Edmundowicz SA. Intragastric balloons for weight loss: Not just occupying space in the stomach. Obesity (Silver Spring). 2016 Sep;24(9):1833. PubMed PMID: 27466068
  • Kirk EP, Sullivan S, Klein S. Single Bout Of Aerobic Exercise Reduces Intrahepatic And Intramyocellular Triglyceride In Obese Individuals With Nafld: 3187 Board #252 June 3, 2: 00 PM - 3: 30 PM. Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):909. PubMed PMID: 27361756
  • Pannala R, Abu Dayyeh BK, Aslanian HR, Enestvedt BK, Komanduri S, Manfredi M, Maple JT, Navaneethan U, Parsi MA, Smith ZL, Sullivan SA, Thosani N, Banerjee S. Per-oral endoscopic myotomy (with video). Gastrointest Endosc. 2016 Jun;83(6):1051-60. PubMed PMID: 27033144
  • Thosani N, Abu Dayyeh BK, Sharma P, Aslanian HR, Enestvedt BK, Komanduri S, Manfredi M, Navaneethan U, Maple JT, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE Preservation and Incorporation of Valuable Endoscopic Innovations thresholds for adopting real-time imaging-assisted endoscopic targeted biopsy during endoscopic surveillance of Barrett's esophagus. Gastrointest Endosc. 2016 Apr;83(4):684-98.e7. PubMed PMID: 26874597
  • Pannala R, Abu Dayyeh BK, Aslanian HR, Enestvedt BK, Komanduri S, Manfredi M, Maple JT, Navaneethan U, Parsi MA, Smith ZL, Sullivan SA, Thosani N, Banerjee S. Per-oral endoscopic myotomy (with video). Gastrointest Endosc. 2016 Jun;83(6):1051-60. PubMed PMID: 27033144
  • Komanduri S, Thosani N, Abu Dayyeh BK, Aslanian HR, Enestvedt BK, Manfredi M, Maple JT, Navaneethan U, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S. Cholangiopancreatoscopy. Gastrointest Endosc. 2016 Aug;84(2):209-21. PubMed PMID: 27236413
  • Parsi MA, Sullivan SA, Goodman A, Manfredi M, Navaneethan U, Pannala R, Smith ZL, Thosani N, Banerjee S, Maple JT. Automated endoscope reprocessors. Gastrointest Endosc. 2016 Dec;84(6):885-892. PubMed PMID: 27765382
  • Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, Bour E, Edmundowicz S, Snyder B, Soto F, Sullivan S, Holcomb R, Lehmann J. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015 Jul-Aug;11(4):874-81. PubMed PMID: 25868829
  • Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015 Sep;82(3):425-38.e5. PubMed PMID: 26232362
  • Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. Endoscopic bariatric therapies. Gastrointest Endosc. 2015 May;81(5):1073-86. PubMed PMID: 25828245
  • Sullivan S, Kumar N, Edmundowicz SA, Abu Dayyeh BK, Jonnalagadda SS, Larsen M, Thompson CC. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015 Nov;82(5):767-72. PubMed PMID: 26282949
  • Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, Bour E, Edmundowicz S, Snyder B, Soto F, Sullivan S, Holcomb R, Lehmann J. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015 Jul-Aug;11(4):874-81. PubMed PMID: 25868829
  • Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015 Sep;82(3):425-38.e5. PubMed PMID: 26232362
  • Pepino MY, Bradley D, Eagon JC, Sullivan S, Abumrad NA, Klein S. Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity (Silver Spring). 2014 May;22(5):E13-20. PubMed PMID: 24167016
  • Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, Mittendorfer B. A ~60-min brisk walk increases insulin-stimulated glucose disposal but has no effect on hepatic and adipose tissue insulin sensitivity in older women. J Appl Physiol (1985). 2013 Jun;114(11):1563-8. PubMed PMID: 23493357
  • Sullivan S. Endoscopy in the management of obesity. Gastrointest Endosc Clin N Am. 2013 Jan;23(1):165-75. PubMed PMID: 23168126
  • Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, Mittendorfer B. A ~60-min brisk walk increases insulin-stimulated glucose disposal but has no effect on hepatic and adipose tissue insulin sensitivity in older women. J Appl Physiol (1985). 2013 Jun;114(11):1563-8. PubMed PMID: 23493357
  • Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013 Dec;145(6):1245-52.e1-5. PubMed PMID: 24012983
  • Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012 Jun;55(6):1738-45. PubMed PMID: 22213436
  • Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012 Jun;55(6):1738-45. PubMed PMID: 22213436
  • Sullivan S, Fabbrini E, Horton JD, Korenblat K, Patterson BW, Klein S. Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people. Transl Res. 2011 Nov;158(5):302-6. PubMed PMID: 22005270
  • Sullivan S, Fabbrini E, Horton JD, Korenblat K, Patterson BW, Klein S. Lack of a relationship between plasma PCSK9 concentrations and hepatic lipoprotein kinetics in obese people. Transl Res. 2011 Nov;158(5):302-6. PubMed PMID: 22005270
  • Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010 Feb;51(2):679-89. PubMed PMID: 20041406
  • Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2010 Mar;26(2):160-4. PubMed PMID: 20010099
  • Sullivan S, Cloninger CR, Przybeck TR, Klein S. Personality characteristics in obesity and relationship with successful weight loss. Int J Obes (Lond). 2007 Apr;31(4):669-74. PubMed PMID: 16953251
  • Sullivan S, Cloninger CR, Przybeck TR, Klein S. Personality characteristics in obesity and relationship with successful weight loss. Int J Obes (Lond). 2007 Apr;31(4):669-74. PubMed PMID: 16953251
  • Sullivan S, Samuel S. Effect of short-term Pritikin diet therapy on the metabolic syndrome. J Cardiometab Syndr. 2006 Fall;1(5):308-12. PubMed PMID: 17679787
  • Sullivan S, Samuel S. Effect of short-term Pritikin diet therapy on the metabolic syndrome. J Cardiometab Syndr. 2006 Fall;1(5):308-12. PubMed PMID: 17679787
  • Gazdag AC, Sullivan S, Kemnitz JW, Cartee GD. Effect of long-term caloric restriction on GLUT4, phosphatidylinositol-3 kinase p85 subunit, and insulin receptor substrate-1 protein levels in rhesus monkey skeletal muscle. J Gerontol A Biol Sci Med Sci. 2000 Jan;55(1):B44-6; discussion B47-8. PubMed PMID: 10719762
  • Gazdag AC, Sullivan S, Kemnitz JW, Cartee GD. Effect of long-term caloric restriction on GLUT4, phosphatidylinositol-3 kinase p85 subunit, and insulin receptor substrate-1 protein levels in rhesus monkey skeletal muscle. J Gerontol A Biol Sci Med Sci. 2000 Jan;55(1):B44-6; discussion B47-8. PubMed PMID: 10719762
View All (77 Total) View Less

Practice Locations

UCHealth Digestive Health Center - Anschutz Medical Campus
1635 Aurora Ct
5th Floor
Aurora, CO 80045
720-848-2777

CU Medicine Weight Management and Wellness - Anschutz Health and Wellness Center
12348 E Montview Boulevard
Aurora, CO 80045
303-724-9030

UCHealth Metabolic and Bariatric Endoscopy - Anschutz
1635 Aurora Court
Anschutz Outpatient Pavilion, 5th Fl
Aurora, CO 80045
720-848-2777

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Gastroenterology, Board Certification
  • Obesity Medicine
  • Gastroenterology, Board Certification (2017)
  • Obesity Medicine, Board Certification (2016)
  • Internal Medicine, Board Certification (2014)
Conditions & Treatments
  • Food, Nutrition and Metabolism - Obesity
  • Food, Nutrition and Metabolism
  • Wellness and Prevention
Clinical Interests
My main clinical interest is in the treatment of obesity in a comprehensive program. I am also a national leader in non-surgical procedures done during an endoscopy for weight loss. Please see our UCHealth website to learn more about these procedures: https://www.uchealth.org/services/weight-and-metabolism/metabolic-and-bariatric-endoscopy/

Care Philosophy
I am board certified in Internal Medicine, Gastroenterology, and Obesity Medicine. In my practice I use all of the tools currently available to help patients lose weight in a healthy way and maintain their weight loss long-term.

Personal Interests
• Completed a half Iron Man with mom to celebrate her 70.3-year birthday • Loves to run, bike and ski • Likes to cook vegetables

General Information

Medical Schools:
  • MD, Washington University in St. Louis School of Medicine (2001)
Undergraduate Schools:
  • BA, University of Wisconsin–Madison (WI) (1997)
Internships:
  • Washington University in St. Louis (2002)
Residency Programs:
  • Washington University in St. Louis, Internal Medicine (2004)
Fellowships:
  • Washington University in St. Louis, Gastroenterology (2007)
Department: Medicine-Gastroenterology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;